Market Tracker

10/24 6:05pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

38.48
Data as of Oct 24
 -0.60 / -1.54%
Today’s Change
16.00
Today|||52-Week Range
53.48
+74.83%
Year-to-Date

Today’s Trading

Previous close39.08
Today’s open39.40
Day’s range37.05 - 42.00
Volume3,223,129
Average volume (3 months)910,501
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-9.82%
Earnings growth (this year)-23.25%
Earnings growth (next 5 years)--
Revenue growth (last year)-35.21%
P/E ratioNM
Price/Sales508.97
Price/Book17.53

Competitors

 Today’s
change
Today’s
% change
USNAUSANA Health Science...+0.40+0.47%
SGNTSagent Pharmaceutica...-0.28-0.86%
LGNDLigand Pharmaceutica...-0.16-0.30%
TSROTESARO Inc+0.82+3.01%
Data as of 4:02pm ET, 10/24/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$1.1M
Annual profit (last year)-$31.2M
Net profit margin-2,852.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts